The course and correlates of everyday functioning in schizophrenia
AHIP and payer CEOs have pointed to these benefits in pledging to adopt ePA standards ( [42] ) ( [14] )
Doctors don't know if it's the GLP-1 drug itself that's causing potential eye problems or if they're due to the rapid lowering of the blood sugar that can come with the medication, which can be a shock to the system, he adds
Available from: Isaacs J, Gonalves J, Strohal R, Castaeda-Hernndez G, Azevedo V, Drner T, et al
What made exendin-4 particularly interesting was its resistance to degradation in the body and its longer-lasting effects compared to native human GLP-1
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, et al